Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma.
Wang S, Xiong Y, Luo Y, Shen Y, Zhang F, Lan H, Pang Y, Wang X, Li X, Zheng X, Lu X, Liu X, Cheng Y, Wu T, Dong Y, Lu Y, Cui J, Jia X, Yang S, Wang L, Wang Y.
Wang S, et al. Among authors: xiong y.
EMBO Mol Med. 2024 May;16(5):1115-1142. doi: 10.1038/s44321-024-00060-y. Epub 2024 Apr 3.
EMBO Mol Med. 2024.
PMID: 38570712
Free PMC article.